Affiliation:
1. Infectious Disease Research Laboratory, Loyola University Medical Center, Maywood, Illinois 60153.
Abstract
The in vitro activities of beta-lactam antibiotics against Bacteroides fragilis and B. fragilis group isolates are presented. Clinical isolates from 1986 were compared with strains from 1979 to 1982. Imipenem, ticarcillin-clavulanic acid, and ceftizoxime were the most active agents. Cefotetan was equivalent to cefoxitin against B. fragilis but less active against B. fragilis group isolates. Enhancement of cefotaxime by its desacetyl metabolite was minimal.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference13 articles.
1. Comparative activity of P-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with P-lactams against ,-lactamase-producing anaerobes;Appelbaum P. C.;Antimicrob. Agents Chemother.,1986
2. Comparative evaluation of ceftizoxime with clindamycin and gentamicin and cefoxitin in the treatment of post cesarean endomyometritis;Apuzzio J. J.;Surg. Gynecol. Obstet.,1985
3. Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982;Cuchural G. J.;Antimicrob. Agents Chemother.,1984
4. Clinical pharmacokinetics of cefotaxime in patients with normal and reduced renal function;Doluisio J. T.;Rev. Infect. Dis.,1982
5. Activity of cefazolin and two P-lactamase inhibitors, clavulanic acid and sulbactam, against Bacteroides fragilis;Fekete T.;Antimicrob. Agents Chemother.,1987
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献